151 related articles for article (PubMed ID: 32515342)
1. [Statins and COPD: relationship with inflammation, exacerbations and mortality].
Damkjær M; Håkansson KEJ; Ulrik CS; Godtfredsen NS
Ugeskr Laeger; 2020 Jun; 182(23):. PubMed ID: 32515342
[TBL] [Abstract][Full Text] [Related]
2. Statin Effects on Exacerbation Rates, Mortality, and Inflammatory Markers in Patients with Chronic Obstructive Pulmonary Disease: A Review of Prospective Studies.
Howard ML; Vincent AH
Pharmacotherapy; 2016 May; 36(5):536-47. PubMed ID: 26990316
[TBL] [Abstract][Full Text] [Related]
3. Clinical Studies of Statins in Asthma and COPD.
Thomson NC
Curr Mol Pharmacol; 2017; 10(1):60-71. PubMed ID: 26758945
[TBL] [Abstract][Full Text] [Related]
4. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.
Lin CM; Yang TM; Yang YH; Tsai YH; Lee CP; Chen PC; Chen WC; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2020; 15():289-299. PubMed ID: 32103928
[TBL] [Abstract][Full Text] [Related]
5. The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: a systematic review and meta-analysis of observational research.
Cao C; Wu Y; Xu Z; Lv D; Zhang C; Lai T; Li W; Shen H
Sci Rep; 2015 Nov; 5():16461. PubMed ID: 26553965
[TBL] [Abstract][Full Text] [Related]
6. [Statins in COPD--theoretical reflections].
Hannink JD; Heijdra YF
Ned Tijdschr Geneeskd; 2010; 154():A2196. PubMed ID: 20977805
[TBL] [Abstract][Full Text] [Related]
7. Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.
Frantzi N; Nguyen XP; Herr C; Alter P; Söhler S; Soriano D; Watz H; Waschki B; Trinkmann F; Eichenlaub M; Trudzinski FC; Michels-Zetsche JD; Omlor A; Seiler F; Moneke I; Biertz F; Rohde G; Stolz D; Welte T; Kauczor HU; Kahnert K; Jörres RA; Vogelmeier CF; Bals R; Fähndrich S;
Respir Res; 2024 May; 25(1):207. PubMed ID: 38750572
[TBL] [Abstract][Full Text] [Related]
8. Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink.
Smith MC; Ashdown HF; Sheppard JP; Butler CC; Bankhead C
BMJ Open; 2021 Dec; 11(12):e050757. PubMed ID: 34876426
[TBL] [Abstract][Full Text] [Related]
9. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
10. Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study.
Damkjær M; Håkansson K; Kallemose T; Ulrik CS; Godtfredsen N
Int J Chron Obstruct Pulmon Dis; 2021; 16():579-589. PubMed ID: 33707941
[TBL] [Abstract][Full Text] [Related]
11. Statins in COPD: a systematic review.
Janda S; Park K; FitzGerald JM; Etminan M; Swiston J
Chest; 2009 Sep; 136(3):734-743. PubMed ID: 19376844
[TBL] [Abstract][Full Text] [Related]
12. Risk of COPD Exacerbations Associated with Statins versus Fibrates: A New User, Active Comparison, and High-Dimensional Propensity Score Matched Cohort Study.
Sun SH; Chang CH; Zhan ZW; Chang WH; Chen YA; Dong YH
Int J Chron Obstruct Pulmon Dis; 2021; 16():2721-2733. PubMed ID: 34621122
[TBL] [Abstract][Full Text] [Related]
13. The role of statins in chronic obstructive pulmonary disease: is cardiovascular disease the common denominator?
Amariei DE; Reed RM
Curr Opin Pulm Med; 2019 Mar; 25(2):173-178. PubMed ID: 30418244
[TBL] [Abstract][Full Text] [Related]
14. Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities.
Young RP; Hopkins RJ
Expert Rev Respir Med; 2013 Oct; 7(5):533-44. PubMed ID: 24138695
[TBL] [Abstract][Full Text] [Related]
15. Effect of Statins on COPD: A Meta-Analysis of Randomized Controlled Trials.
Zhang W; Zhang Y; Li CW; Jones P; Wang C; Fan Y
Chest; 2017 Dec; 152(6):1159-1168. PubMed ID: 28847550
[TBL] [Abstract][Full Text] [Related]
16. The stats are in: an update on statin use in COPD.
Carlson AA; Smith EA; Reid DJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():2277-84. PubMed ID: 26543360
[TBL] [Abstract][Full Text] [Related]
17. Statin use and risk of COPD exacerbation requiring hospitalization.
Wang MT; Lo YW; Tsai CL; Chang LC; Malone DC; Chu CL; Liou JT
Am J Med; 2013 Jul; 126(7):598-606.e2. PubMed ID: 23684060
[TBL] [Abstract][Full Text] [Related]
18. Statin use and exacerbations in individuals with chronic obstructive pulmonary disease.
Ingebrigtsen TS; Marott JL; Nordestgaard BG; Lange P; Hallas J; Vestbo J
Thorax; 2015 Jan; 70(1):33-40. PubMed ID: 25349333
[TBL] [Abstract][Full Text] [Related]
19. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
[TBL] [Abstract][Full Text] [Related]
20. Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence.
Young RP; Hopkins R; Eaton TE
Postgrad Med J; 2009 Aug; 85(1006):414-21. PubMed ID: 19633007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
